DYNE THERAPEUTICS INC (DYN:NASDAQ)
$25.14 0.04 (0.1594%)
Analysed DYNE THERAPEUTICS INC (DYN:NASDAQ) News Sources
Dyne Therapeutics to Participate in Upcoming Investor Conferences
02-09-2026
yahoo.com
DYN Stock Rises 19.2% in 3 Months: What's Driving the Rally?
21-07-2026
yahoo.com
Dyne Therapeutics vs. Recursion Pharmaceuticals: Which Development Stage Pharma Stock Is a Better Buy in 2026?
04-07-2026
fool.com
Dyne Therapeutics Announces U.S. FDA Acceptance of Biologics License Application (BLA) for Z-Rostudirsen in Exon 51 Duchenne Muscular Dystrophy (DMD)
20-07-2026
yahoo.com
Sarepta Skids After A Rival Clears A Key Hurdle In The Duchenne Space
20-07-2026
yahoo.com
SRPT Stock Drops 4% As Citi Flags Potentially Stronger Rival In Duchenne Space
21-07-2026
stocktwits.com
Why DYN Shares Are Down 10% After-Hours? Day After An FDA Win, Another Announcement Rocks Stock
22-07-2026
stocktwits.com
Dyne Therapeutics Announces Pricing of Upsized $375 Million Public Offering of Common Stock
22-07-2026
yahoo.com
Dyne Therapeutics shares slide after pricing $375 million public offering (NASDAQ:DYN)
22-07-2026
advfn.com
Dyne Therapeutics (DYN) Prices Upsized Share Offering, Is The Valuation Still Compelling?
23-07-2026
yahoo.com
What is the current price of DYNE THERAPEUTICS INC (DYN:NASDAQ)?
The current price of DYNE THERAPEUTICS INC (DYN:NASDAQ) is $25.14.
DYNE THERAPEUTICS INC (DYN:NASDAQ) absolute price change since previous trading day?
The absolute price change of DYNE THERAPEUTICS INC (DYN:NASDAQ) since the previous trading day is $0.04.
DYNE THERAPEUTICS INC (DYN:NASDAQ) percentage price change since previous trading day?
The percentage price change of DYNE THERAPEUTICS INC (DYN:NASDAQ) since the previous trading day is 0.1594%.
What is the most recent average sentiment score for DYNE THERAPEUTICS INC (DYN:NASDAQ)?
The most recent average sentiment score for DYNE THERAPEUTICS INC (DYN:NASDAQ) is 71 out of 100.
What is the most recent average sentiment for DYNE THERAPEUTICS INC (DYN:NASDAQ)?
The most recent sentiment for DYNE THERAPEUTICS INC (DYN:NASDAQ) is .
SEC-8K** Filing Available For DYNE THERAPEUTICS INC (DYN:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.